TVARDI THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
TVARDI THERAPEUTICS, INC. (TVRD) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 250.27 thousand shares as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-05-13
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 250.27K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 566.32K shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 775.71K shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 791.85K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2024-03-31 | 250.27K shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 566.32K shares 10-K · filed 2024-03-06 |
| 2023-09-30 | 775.71K shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 791.85K shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 695.72K shares 10-Q · filed 2024-05-13 |
| 2022-12-31 | 372.51K shares 10-K · filed 2024-03-06 |
| 2022-09-30 | 640.95K shares 10-Q · filed 2023-11-13 |
| 2022-06-30 | 648.45K shares 10-Q · filed 2023-08-07 |
| 2022-03-31 | 736.27K shares 10-Q · filed 2023-05-15 |
| 2021-12-31 | 576.54K shares 10-K · filed 2024-03-06 |
| 2021-09-30 | 365.03K shares 10-Q · filed 2022-11-07 |
| 2021-06-30 | 409.03K shares 10-Q · filed 2022-08-08 |
| 2021-03-31 | 401.83K shares 10-Q · filed 2022-05-09 |
| 2020-12-31 | 235.25K shares 10-K · filed 2023-03-06 |
| 2020-09-30 | 272.00K shares 10-Q · filed 2021-11-08 |
| 2020-06-30 | 272.00K shares 10-Q · filed 2021-08-09 |
| 2020-03-31 | 355.83K shares 10-Q · filed 2021-05-10 |
| 2019-12-31 | 119.83K shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |